1. Medical Action Industries — future earnings growth of 100.8 percent
2. RTI Biologics — future earnings growth of 43.7 percent
3. Vascular Solutions — future earnings growth of 40.5 percent
4. Merit Medical Systems — future earnings growth of 23.8 percent
5. Winner Medical Group — future earnings growth of 21.4 percent
Read the Zacks Investment Research report on companies with high future earnings growth.
Read more on supply chain issues:
–5 Keys to Successful Product Standardization in ASCs
–Drug Distributors Will Experience Continuing Growth
–Study: Few Health Advocacy Groups Disclose Funding From Drug Makers
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.